Clinical Trial Update: Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab, temozolomide, and hypofractionated radiotherapy in newly diagnosed malignant glioma; study status completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Malignant Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Cancer, Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2018-02-06